Skip To Content
Get Our Newsletter
JEWISH. INDEPENDENT. NONPROFIT.

Support the Forward

Funded by readers like you DonateSubscribe
Life

Why Jewish Women Are a Challenging Demographic in Fight Against Breast Cancer

Public health officials trying to fight breast cancer in Australia find the country’s Jewish population especially challenging.

That’s because Australia’s Jewish community of 112,000 is overwhelmingly Ashkenazi, or of European origin, and counts a high number of descendents of Holocaust survivors, said Lesley Andrews, a doctor at Prince of Whales hospital in Randwick, Australia. Andrews presented at “Lessons from the Jewish Genome,” a conference on Jewish genetics in Haifa on July 13.

Ashkenazi Jews are about 10 times more likely than the general population to have BRCA1 and BRCA2 gene mutations, those harmful mutations that can lead to the development of breast cancer.

The decision to get tested for these gene mutations often hinges on family history. If other female relatives were diagnosed with breast cancer, it’s a clear sign that a woman should get tested herself. But many Australian Jews don’t know their family’s long-term cancer history because their family ties were severed in the Holocaust.

Andrews, along with researchers Nicole Cousens and Bettine Meiser, conducted a survey in the Australian Jewish community about the possibility of creating community program that would make it easier for Australian Jews to get tested, regardless of family breast cancer history. The “bottom line” is saving women’s lives, Andrews said.

Of the 370 respondents, “97 percent supported a Jewish community-based BRCA 1/2 testing program, and 66% reported being personally interested in undergoing the test,” according to an abstract provided by the researchers.

Andrews and her co-researchers proposed creating an interactive web site to support Jewish community members with counseling around the topic of genetic testing.

Contact Naomi Zeveloff at Zeveloff@forward.com or on Twitter @naomizeveloff

Engage

  • SHARE YOUR FEEDBACK

  • UPCOMING EVENT

Republish This Story

Please read before republishing

We’re happy to make this story available to republish for free under an Attribution-Non Commercial-No Derivatives Creative Commons license as long as you follow our republishing guidelines, which require that you credit the Foward and retain our pixel. See our full guidelines for more information.

To republish, copy the HTML, which includes our tracking pixel, all paragraph styles and hyperlinks, the author byline, images, and credit to the Foward. Have questions? Please email us at editorial@forward.com.

We don't support Internet Explorer

Please use Chrome, Safari, Firefox, or Edge to view this site.